Monterola, Julife M.

HRN: 23-06-89  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/22/2023
07/28/2023
IV
500 Mg
Q 8 Hours
Amebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: